BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6231603)

  • 1. [Monotherapy of Pseudomonas aeruginosa septicemia with azlocillin].
    Godard J; Aubertin J; Borderon JC; Dureux JB; Motin J
    Presse Med; 1984 Mar; 13(13):819-21. PubMed ID: 6231603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of azlocillin in the treatment of Pseudomonas bronchopulmonary infections].
    Arnaud A; Gevaudan MJ; Saadjian M; Dugue P; Charpin J
    Presse Med; 1984 Mar; 13(13):834-7. PubMed ID: 6231607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Role of azlocillin in the treatment of Pseudomonas urinary infections].
    Canton P
    Presse Med; 1984 Mar; 13(13):830-3. PubMed ID: 6231606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
    Konopka CA
    Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Azlocillin treatment of Pseudomonas aeruginosa bronchopulmonary infections in children with cystic fibrosis].
    Grenier B; Gilly R
    Presse Med; 1984 Mar; 13(13):815-8. PubMed ID: 6231602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pseudomonas aeruginosa meningitis treated with azlocillin. 5 cases].
    Vilde JL; Vachon F; Humbert G; Bure A; Bricaire F
    Presse Med; 1984 Mar; 13(13):822-4. PubMed ID: 6231604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current chemotherapy of infections caused by Pseudomonas aeruginosa (author's transl)].
    Bauernfeind A; Petermüller C; Dietzel M
    Infection; 1979; 7(1):21-6. PubMed ID: 422252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
    Gwynn MN; Rolinson GN
    Infection; 1980; 8(2):73-80. PubMed ID: 6771215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of multiresistant pseudomonas peritonitis with combination of azlocillin and amikacin.
    Leung AC; Gribben J; Sleigh JD; Boulton Jones JM
    Scott Med J; 1983 Jan; 28(1):69-70. PubMed ID: 6403983
    [No Abstract]   [Full Text] [Related]  

  • 13. Pseudomonas aeruginosa meningitis treated with an azlocillin combination.
    Davidson S; Yellin EO; Shaked I; Rubinstein E
    Infection; 1982; 10 Suppl 3():S168-9. PubMed ID: 6818154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanisms of azlocillin resistance in Pseudomonas aeruginosa].
    Labia R; Morand A; Ben Yaghlane H
    Presse Med; 1984 Mar; 13(13):777-9. PubMed ID: 6231594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparison of in vitro bacteriostatic effect of five betalactamins against Pseudomonas aeruginosa (author's transl)].
    Lesage D; Delisle-Mizon F; Denis C; Vergez P; Daguet GL
    Pathol Biol (Paris); 1982 Jun; 30(6):440-3. PubMed ID: 6213917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE; Høiby N
    Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of azlocillin to treat serious infections.
    Neu HC; Francke EL; Ortiz-Neu C; Prince AS
    J Antimicrob Chemother; 1983 May; 11 Suppl B():141-7. PubMed ID: 6619023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of pseudomonas infection with the new ureidopenicillin, azlocillin (author's transl)].
    Helm EB; Ristow W; Shah PM; Schacht P; Stille W
    Dtsch Med Wochenschr; 1977 Aug; 102(34):1211-6. PubMed ID: 913249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azlocillin in respiratory tract infections with Pseudomonas aeruginosa in children with cystic fibrosis.
    Michalsen H; Bergan T
    Chemotherapy; 1980; 26(2):135-40. PubMed ID: 7363708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azlocillin compared with carbenicillin in the treatment of bronchopulmonary infection due to Pseudomonas aeruginosa in cystic fibrosis.
    Penketh A; Hodson ME; Gaya H; Batten JC
    Thorax; 1984 Apr; 39(4):299-304. PubMed ID: 6426075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.